CNBC Cures

Join us for the first annual CNBC Cures Summit, a landmark live event bringing together the most influential investors, policy makers and leaders in biotechnology to accelerate the future of medicine through breakthroughs in rare disease research. Becky Quick moderates a series of dynamic conversations focused on tackling the biggest bottlenecks slowing progress: regulatory gridlock, outdated healthcare frameworks, fragmented research, funding challenges, and barriers to global patient access. The Cures Summit will feature stakeholders with the ability to drive real change, the visionary leaders rethinking what personalized healthcare can be, and the individuals building the models that will power the next generation of cures. Designed to convene decision-makers from across the world, the CNBC Cures Summit is more than a conference. It is a call to action: to reimagine healthcare, unlock bold new solutions, and accelerate a future where scientific breakthroughs for the rare disease community drive better outcomes for us all.